Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7996
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShen, Limei-
dc.contributor.authorHiguchi, Tetsuya-
dc.contributor.authorTubbe, Ingrid-
dc.contributor.authorVoltz, Nicole-
dc.contributor.authorKrummen, Mathias-
dc.contributor.authorPektor, Stefanie-
dc.contributor.authorMontermann, Evelyn-
dc.contributor.authorRausch, Kristin-
dc.contributor.authorSchmidt, Manfred-
dc.contributor.authorSchild, Hansjörg-
dc.contributor.authorGrabbe, Stephan-
dc.contributor.authorBros, Matthias-
dc.date.accessioned2022-10-14T07:10:12Z-
dc.date.available2022-10-14T07:10:12Z-
dc.date.issued2013-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/8011-
dc.description.abstractDendritic cells (DCs) constitute an attractive target for specific delivery of nanovaccines for immunotherapeutic applications. Here we tested nano-sized dextran (DEX) particles to serve as a DC-addressing nanocarrier platform. Non-functionalized DEX particles had no immunomodulatory effect on bone marrow (BM)-derived murine DCs in vitro. However, when adsorbed with ovalbumine (OVA), DEX particles were efficiently engulfed by BM-DCs in a mannose receptor-dependent manner. A DEX-based nanovaccine containing OVA and lipopolysaccharide (LPS) as a DC stimulus induced strong OVA peptide-specific CD4(+) and CD8(+) T cell proliferation both in vitro and upon systemic application in mice, as well as a robust OVA-specific humoral immune response (IgG1>IgG2a) in vivo. Accordingly, this nanovaccine also raised both a more pronounced delayed-type hypersensitivity response and a stronger induction of cytotoxic CD8(+) T cells than obtained upon administration of OVA and LPS in soluble form. Therefore, DEX-based nanoparticles constitute a potent, versatile and easy to prepare nanovaccine platform for immunotherapeutic approaches.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleA trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivoen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7996-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.departmentFB 09 Chemie, Pharmazie u. Geowissensch.de
jgu.organisation.number2700-
jgu.organisation.number7950-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titlePLoS onede
jgu.journal.volume8de
jgu.journal.issue12de
jgu.pages.alternativee80904de
jgu.publisher.year2013-
jgu.publisher.namePLoSde
jgu.publisher.placeLawrence, Kan.de
jgu.publisher.urihttp://dx.doi.org/10.1371/journal.pone.0080904de
jgu.publisher.issn1932-6203de
jgu.organisation.placeMainz-
jgu.identifier.pmid24339889-
jgu.subject.ddccode610de
opus.date.modified2018-08-08T09:09:52Z-
opus.subject.dfgcode00-000-
opus.organisation.stringFB 04: Medizin: Institut für Immunologiede_DE
opus.organisation.stringFB 04: Medizin: Klinik und Poliklinik für Nuklearmedizinde_DE
opus.organisation.stringFB 04: Medizin: Hautklinikde_DE
opus.organisation.stringFB 09: Chemie, Pharmazie und Geowissenschaften: Institut für Physikalische Chemiede_DE
opus.identifier.opusid27386-
opus.importsourcepubmed-
opus.institute.number0412-
opus.institute.number0422-
opus.institute.number0431-
opus.institute.number0906-
opus.metadataonlyfalse-
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN
opus.affiliatedPektor, Stefanie-
opus.affiliatedSchmidt, Manfred-
opus.affiliatedSchild, Hansjörg-
opus.affiliatedGrabbe, Stephan-
opus.affiliatedBros, Matthias-
jgu.publisher.doi10.1371/journal.pone.0080904de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
a_trifunctional_dextranbased_-20220925162029392.pdf1.73 MBAdobe PDFView/Open